Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Clinical prospective study of visual function in patients with acute optic neuritis.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Safety of TNF inhibitors in adolescents and children.
Subcutaneous IgG in neurologic diseases.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »